SCHEMBL18370272

SCHEMBL18370272

c1ccc(-c2cccc(-c3nc(-c4cccc(-c5cccc(-c6cc7ccccc7c7ccccc67)c5)c4)nc4c3sc3ccccc34)c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 1/20 0.36
▸ LIMK1 P53667 4/20 0.34
▸ ALOX5 P09917 1/20 0.33
▸ MAP3K8 P41279 5/20 0.33
▸ PIM1 P11309 2/20 0.33
▸ PIM2 Q9P1W9 2/20 0.33
▸ PIM3 Q86V86 1/20 0.33
▸ RORB Q92753 1/20 0.33
▸ TNKS O95271 2/20 0.32
▸ TNKS2 Q9H2K2 2/20 0.32
▸ MAPK1 P28482 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ RECQL P46063 1/20 0.31
▸ MMP14 P50281 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16902029 0.97 CYP11B1 (0.37) CYP11B1LIMK1ALOX5MAP3K8PIM1
SCHEMBL19106383 0.92 CYP11B1 (0.36) CYP11B1LIMK1ALOX5MAP3K8PIM1
SCHEMBL18370254 0.91 LIMK1 (0.39) LIMK1PIM1PIM2PIM3RORB
SCHEMBL18370255 0.91 LIMK1 (0.39) LIMK1PIM1PIM2PIM3RORB
SCHEMBL16902192 0.91 LIMK1 (0.39) LIMK1PIM1PIM2PIM3RORB
SCHEMBL16902225 0.91 LIMK1 (0.39) LIMK1PIM1PIM2PIM3RORB
SCHEMBL16902397 0.91 LIMK1 (0.39) LIMK1PIM1PIM2PIM3RORB
SCHEMBL18370257 0.91 LIMK1 (0.39) LIMK1PIM1PIM2PIM3RORB
SCHEMBL18370235 0.90 F9 (0.36) LIMK1ALOX5MAP3K8PIM1PIM2
SCHEMBL18370233 0.90 F9 (0.36) LIMK1ALOX5MAP3K8PIM1PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170012216-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2017-01-12 — — US disclosed
US-20170012216-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2017-01-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170012216-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP11B1 1478/4885LIMK1 1263/4885ALOX5 1855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback